Signpost Corp. (Tokyo)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3312170008
JPY
272.00
5 (1.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor Management Efficiency with a low ROE of 4.79%

  • The company has been able to generate a Return on Equity (avg) of 4.79% signifying low profitability per unit of shareholders funds
2

The company has declared negative results in Feb'2025 after 5 consecutive positive quarters

3

With ROE of 14.34%, it has a attractive valuation with a 2.44 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 3,609 Million (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.75

stock-summary
Return on Equity

5.18%

stock-summary
Price to Book

2.00

Revenue and Profits:
Net Sales:
797 Million
(Quarterly Results - Nov 2025)
Net Profit:
25 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.51%
0%
-2.51%
6 Months
-12.82%
0%
-12.82%
1 Year
-32.17%
0%
-32.17%
2 Years
-47.18%
0%
-47.18%
3 Years
-54.89%
0%
-54.89%
4 Years
-70.27%
0%
-70.27%
5 Years
-73.33%
0%
-73.33%

Signpost Corp. (Tokyo) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.34%
EBIT Growth (5y)
25.66%
EBIT to Interest (avg)
-64.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
1.41
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.37%
ROE (avg)
4.79%

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.44
EV to EBIT
15.97
EV to EBITDA
15.96
EV to Capital Employed
5.36
EV to Sales
1.06
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
33.54%
ROE (Latest)
14.34%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 6.14% vs 6.87% in Aug 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 1,236.36% vs 91.02% in Aug 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "797.10",
          "val2": "751.00",
          "chgp": "6.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.30",
          "val2": "-0.80",
          "chgp": "3,512.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.70",
          "chgp": "-23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.00",
          "val2": "-2.20",
          "chgp": "1,236.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.00%",
          "val2": "-1.20%",
          "chgp": "3.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 3.20% vs 13.81% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is 99.69% vs 197.13% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,023.50",
          "val2": "2,929.70",
          "chgp": "3.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "200.20",
          "val2": "101.80",
          "chgp": "96.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "6.50",
          "chgp": "-58.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.30",
          "val2": "-20.00",
          "chgp": "93.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "257.20",
          "val2": "128.80",
          "chgp": "99.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.20%",
          "val2": "34.70%",
          "chgp": "3.15%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQstock-summary

Nov'25
Aug'25
Change(%)
Net Sales
797.10
751.00
6.14%
Operating Profit (PBDIT) excl Other Income
27.30
-0.80
3,512.50%
Interest
1.30
1.70
-23.53%
Exceptional Items
-0.40
0.00
Consolidate Net Profit
25.00
-2.20
1,236.36%
Operating Profit Margin (Excl OI)
34.00%
-1.20%
3.52%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Nov 2025 is 6.14% vs 6.87% in Aug 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is 1,236.36% vs 91.02% in Aug 2025

Annual Results Snapshot (Consolidated) - Feb'25stock-summary

Feb'25
Feb'24
Change(%)
Net Sales
3,023.50
2,929.70
3.20%
Operating Profit (PBDIT) excl Other Income
200.20
101.80
96.66%
Interest
2.70
6.50
-58.46%
Exceptional Items
-1.30
-20.00
93.50%
Consolidate Net Profit
257.20
128.80
99.69%
Operating Profit Margin (Excl OI)
66.20%
34.70%
3.15%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2025 is 3.20% vs 13.81% in Feb 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2025 is 99.69% vs 197.13% in Feb 2024

stock-summaryCompany CV
About Signpost Corp. (Tokyo) stock-summary
stock-summary
Signpost Corp. (Tokyo)
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available